Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
Moderna, Inc. continues to funnel the revenue and exposure gained from its COVID-19 vaccine SpikeVax into business development; a collaboration with Life Edit Therapeutics, Inc. announced on 22 February is its eighth outside the pandemic-response field since the start of 2021
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?